(Q43955796)

English

Erlotinib hydrochloride

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 November 2017

Erlotinib hydrochloride (English)

1 reference

Europe PubMed Central

28 November 2017

author name string

Jonathan Dowell

1

1 reference

Europe PubMed Central

28 November 2017

John D Minna

2

1 reference

Europe PubMed Central

28 November 2017

Peter Kirkpatrick

3

1 reference

Europe PubMed Central

28 November 2017

publication date

1 January 2005

1 reference

Europe PubMed Central

28 November 2017

Nature Reviews Drug Discovery

1 reference

Europe PubMed Central

28 November 2017

4

1 reference

Europe PubMed Central

28 November 2017

13-14

1 reference

Europe PubMed Central

28 November 2017

1

1 reference

Europe PubMed Central

28 November 2017

https://scigraph.springernature.com/pub.10.1038/nrd1612

0 references

Cancer burden in the year 2000. The global picture

1 reference

https://api.crossref.org/works/10.1038%2FNRD1612

21 January 2018

Issues and progress with protein kinase inhibitors for cancer treatment

1 reference

https://api.crossref.org/works/10.1038%2FNRD1612

21 January 2018

Untangling the ErbB signalling network

1 reference

https://api.crossref.org/works/10.1038%2FNRD1612

21 January 2018

Epidermal growth factor-related peptides and their receptors in human malignancies

1 reference

https://api.crossref.org/works/10.1038%2FNRD1612

21 January 2018

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1038%2FNRD1612

21 January 2018

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

https://api.crossref.org/works/10.1038%2FNRD1612

21 January 2018

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

1 reference

https://api.crossref.org/works/10.1038%2FNRD1612

21 January 2018

Why the epidermal growth factor receptor? The rationale for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FNRD1612

31 March 2020

Identifiers

10.1038/NRD1612

1 reference

Europe PubMed Central

28 November 2017

1 reference

Europe PubMed Central

28 November 2017

reason for deprecated rank

unchecked identifier

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43955796&oldid=2104634840"